IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Dec 2002 (Vol: 2002, Issue: 31)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
BioXell SpA Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
LG Life Sciences to Market Thymitaq® in Republic of Korea Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Section: General
Roche’s Option on Antisoma Published: 2 Dec-2002
By: Business Review Editor
Abstract
Deal Making in the Drug Delivery Sector Published: 2 Dec-2002
By: Business Review Editor
Abstract
Technology Focus: PEGylation Published: 2 Dec-2002
By: Business Review Editor
Abstract
Section: Licensing
CeNeS Licenses MS Treatment to Acorda Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Roche Secured Option on Antisoma Pipeline Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
AlphaRx to License Anticancer Toxin from Select Therapeutics Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Allergan Licenses Phase I Skin Cancer Drug from Peplin Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Lundbeck Strengthens CNS Research Through Acquisition of Synaptic Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Millennium Initiates Cardiovascular Collaboration with The Cleveland Clinic Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Cell Therapeutics Researches Oncology Targets with Hope Heart Institute Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.